Federal Preemption of Prescription Drug Labeling: Antidote for Pharmaceutical Industry Overdosing on State Court Jury Decisions in Products Liability Cases
Del Giorno, John F.
JOHN MARSHALL LAW REVIEW 22(3): 629-656, Spring 1989
Showing items related by title, author, creator and subject.
Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products and Draft Guidances and Two Guidances for Industry on the Content and Format of Labeling for Human Prescription Drug and Biological Products; Final Rule and Notices Unknown author (United States. Food and Drug Administration [FDA], 2006-01-24)